Back to Trades
Harper Molly
DirectorCIK 0001871470
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Harper Molly, Director, has disclosed $3.2M in transactions — all concentrated in CATALYST PHARMACEUTICALS, INC. (CPRX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $621.9K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 17 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly | Director | Disposed | $1.9M |
| Dec 30 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly | Director | Exercise | $0 |
| Dec 16 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly | Director | Sell | $621.9K |
| Dec 10 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly | Director | Exercise | $0 |
| Nov 24 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly | Director | Exercise | $412.5K |
5 filings